Elanco Animal Health IncorporatedELANNYSE
Loading
Operating cash flow minus capital expenditures
3Y CAGR
+2.0%/yr
vs -6.6%/yr prior
Acceleration
+8.6pp
Accelerating
Percentile
P70
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $284.00M | -27.9% |
| 2024 | $394.00M | +236.8% |
| 2023 | $117.00M | -56.3% |
| 2022 | $268.00M | -6.3% |
| 2021 | $286.00M | +181.3% |
| 2020 | $-351.90M | -1418.0% |
| 2019 | $26.70M | -92.4% |
| 2018 | $352.80M | +369.1% |
| 2017 | $75.20M | +64.9% |
| 2016 | $45.60M | - |